Israel’s OCON Healthcare (OCON Therapeutics) has been awarded $13 million of orders for its Intra Uterine Ball (IUB) proprietary platform. The purchasers are South America’s DKT and UK’s Consilient Healthcare, where the product will be fully reimbursed by the National Health Service.
Treating intrauterine conditions
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.